No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1675-1679

  Beishuizen, Edith D ^a   Jukema, J Wouter ^a   Tamsma, Jouke T ^a   Van De Ree, Marcel A ^b   Van Der Vijver, J Carel M ^c   Putter, Hein ^a   Maan, Arie C ^a   Meinders, A Edo ^a   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c LEYENBURG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SILENT MYOCARDIAL INFARCTION;

AWARENESS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLACEBOS; PYRIDINES;

EID: 21544478462     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1675     Document Type: Article

References (27)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1.6: 434-444, 1993
2. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J: Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69-75, 1998
3. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96: 1761-1769, 1997
4. Rutter MK, Wahid ST, McComb JM, Marshall SM: Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 40: 56-61, 2002
5. Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, Selwyn AP: Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 95:324-328, 1997
6. van Boven AJ, Jukema JW, Zwinderman AH, Crijns HJ, Lie KI, Bruschke AV: Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation 94:1503-1505, 1996
7. Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, and Huisman MV: Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care 27:2887-2892, 2004
8. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies: a classification system. Circulation 21:1160-1175, 1960
9. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. AmJ Cardiol 67:1073-1078, 1991
10. Hume L, Oakley GD, Boulton AJ, Hardisty C, Ward JD: Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men. Diabetes Care 9:384-388, 1986
11. Koistinen MJ: Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 301:92-95, 1990
12. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol 79:134-139, 1997
13. Chiariello M, Indolfi C, Cotecchia MR, Sifola C, Romano M, Condorelli M: Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 110:529-534, 1985
14. Naka M, Hiramatsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S, Ishihara F, Niwa A, Yamada T: Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 123:46-53, 1992
15. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V: Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 22: 1396-1400, 1999
16. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339-343, 2001
17. Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, Kawano T, Murao H, Doi T, Nawata H: High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 47:37-44, 2000
18. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P: Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. Diabetes Care 25:1418-1424, 2002
19. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, Mastroianno S, De Cosmo S, Fanelli R, Trischitta V: Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 147:649-654, 2002
20. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954-1961, 2004
21. Airaksinen KE: Silent coronary artery disease in diabetes: a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia 44:259-266, 2001
22. Whitsel EA, Boyko EJ, Siscovick DS: Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care 23:241-247, 2000
23. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491-498, 1985
24. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 26:1553-1579, 2003
25. Fredenrich A, Castillo-Ros S, Hieronimus S, Baudouy M, Harter M, Canivet B: Screening for silent myocardial ischemia in diabetic patients (Letter). Diabetes Care 23:563-564, 2000
26. Cosson E, Paycha F, Paries J, Cattan S, Ramadan A, Meddah D, Attali JR, Valensi P: Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med 21:342-348, 2004
27. Lee RT, Libby P: The unstable atheroma. Arleriosder Thromb Vasc Biol 17:1859-1867, 1997